Enrollment Assistant for Phase III Cardiovascular Disease Program

February 9, 2018

Challenge

A leading pharmaceutical company required assistance with two studies in an eight-protocol cardiovascular disease (CVD) program. In addition to needing more enrolled patients, the sponsor knew that sites did not have adequate resources to run this time-intensive program. Media outreach had been provided by another vendor, but participating study sites were not keeping up with media referrals, wasting time and money. By the time ThreeWire joined the program, many referrals had not been followed up with in a timely manner, or not processed at all.

Solution

ThreeWire initiated a pilot program using Enrollment Assistants™ (EAs) to provide on-the-ground support at a total of 18 global study sites: 11 in the US and 7 in Europe. EAs would process media referrals (in the US only) and perform ThreeWire’s Chart Review™ process to identify protocoleligible patients.

Results

ThreeWire EAs processed a total of 734 media referrals in the US, with 63 patients consenting for screening and 18 patients ultimately randomized into the studies. ThreeWire EAs also reviewed 11,837 patient records between the US and Europe, generating 1,539 referrals, 136 consents, and 59 additional randomizations. In total, ThreeWire contributed 77 enrollments for the study, and the sponsor was so pleased with our efforts that they expanded the scope of the program to include support for 250 global sites.

Previous Flipbook
Chart Review Services for Phase II Arthritis Drug -- US & Europe
Chart Review Services for Phase II Arthritis Drug -- US & Europe

Challenge: Complete as many randomizations as possible in this 140-subject study with narrow inclusion cri...

Next Flipbook
Study Marketing for Phase III Pediatric Influenza Vaccine - North America, Europe & Asia
Study Marketing for Phase III Pediatric Influenza Vaccine - North America, Europe & Asia

ThreeWire was called upon to provide study branding and creative services to develop study support material...